Patents by Inventor Nicholas J Newcombe

Nicholas J Newcombe has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20040176386
    Abstract: Compounds of the formula I 1
    Type: Application
    Filed: February 26, 2004
    Publication date: September 9, 2004
    Applicant: AstraZeneca AB
    Inventors: Christophe B. Barlaam, Robert I. Dowell, Maurice R.V. Finlay, Nicholas J. Newcombe, Howard Tucker, David Waterson
  • Publication number: 20040171641
    Abstract: Arylpiperazines of formula (I) useful as metalloproteinase inhibitors, especially as inhibitors of MMP 13.
    Type: Application
    Filed: February 26, 2004
    Publication date: September 2, 2004
    Applicant: AstraZeneca AB
    Inventors: Bernard C. Barlaam, Nicholas J. Newcombe, Howard Tucker, David Waterson
  • Patent number: 6734184
    Abstract: Arylpiperazines of formula (I) useful as metalloproteinase inhibitors, especially as inhibitors of MMP 13.
    Type: Grant
    Filed: February 26, 2001
    Date of Patent: May 11, 2004
    Assignee: AstraZeneca AB
    Inventors: Bernard C Barlaam, Nicholas J Newcombe, Howard Tucker, David Waterson
  • Patent number: 6734183
    Abstract: Compounds of the formula I useful as metalloproteinase inhibitors, especially as inhibitors of MMP 13.
    Type: Grant
    Filed: February 21, 2001
    Date of Patent: May 11, 2004
    Assignee: AstraZeneca AB
    Inventors: Christophe B Barlaam, Robert I Dowell, Maurice R V Finlay, Nicholas J Newcombe, Howard Tucker, David Waterson
  • Publication number: 20020022628
    Abstract: Compounds of the formula I 1
    Type: Application
    Filed: February 21, 2001
    Publication date: February 21, 2002
    Inventors: Christophe B. Barlaam, Robert I. Dowell, Maurice R.V. Finlay, Nicholas J. Newcombe, Howard Tucker, David Waterson